A detailed history of Regent Investment Management LLC transactions in Medtronic PLC stock. As of the latest transaction made, Regent Investment Management LLC holds 4,190 shares of MDT stock, worth $359,292. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,190
Previous 4,890 14.31%
Holding current value
$359,292
Previous $395,000 17.47%
% of portfolio
0.09%
Previous 0.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$76.18 - $87.74 $53,326 - $61,418
-700 Reduced 14.31%
4,190 $326,000
Q3 2022

Oct 18, 2022

BUY
$80.75 - $95.31 $121,125 - $142,965
1,500 Added 44.25%
4,890 $395,000
Q2 2022

Jul 15, 2022

SELL
$87.4 - $113.09 $67,035 - $86,740
-767 Reduced 18.45%
3,390 $304,000
Q1 2022

Apr 19, 2022

SELL
$100.58 - $112.38 $10,058 - $11,238
-100 Reduced 2.35%
4,157 $461,000
Q4 2021

Jan 27, 2022

BUY
$99.53 - $127.75 $49,765 - $63,875
500 Added 13.31%
4,257 $440,000
Q3 2021

Oct 21, 2021

BUY
$122.75 - $135.17 $7,365 - $8,110
60 Added 1.62%
3,757 $471,000
Q1 2021

Apr 20, 2021

BUY
$111.18 - $119.74 $127,857 - $137,701
1,150 Added 45.15%
3,697 $437,000
Q4 2020

Jan 27, 2021

BUY
$100.57 - $117.14 $30,170 - $35,142
300 Added 13.35%
2,547 $298,000
Q3 2020

Oct 19, 2020

BUY
$90.13 - $108.78 $202,522 - $244,428
2,247 New
2,247 $234,000
Q4 2019

Jan 30, 2020

SELL
$104.49 - $114.54 $210,233 - $230,454
-2,012 Closed
0 $0
Q3 2019

Oct 17, 2019

BUY
$98.02 - $111.18 $197,216 - $223,694
2,012 New
2,012 $219,000
Q3 2018

Oct 22, 2018

SELL
$85.91 - $99.17 $360,822 - $416,514
-4,200 Closed
0 $0
Q2 2018

Jul 16, 2018

SELL
$77.48 - $87.83 $15,496 - $17,566
-200 Reduced 4.55%
4,200 $360,000
Q3 2017

Oct 12, 2017

BUY
$77.71 - $84.6 $341,924 - $372,240
4,400
4,400 $342,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $114B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Regent Investment Management LLC Portfolio

Follow Regent Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.